# GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma

> **NCT03723343** · — · UNKNOWN · sponsor: **Guiyang Medical University** · enrollment: 146 (estimated)

## Conditions studied

- Advanced Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** GP+IMRT
- **DRUG:** TPF+IMRT

## Key facts

- **NCT ID:** NCT03723343
- **Lead sponsor:** Guiyang Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-18
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2018-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723343, "GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03723343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*